GlassScriptPhysician profile
Poonam Rai
NPI 1487297099
$5,984.39
in general payments reported to CMS, 2019-2025
57 companies · $971 in 2025
The $971 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $688 · 2023: $1,768 · 2024: $2,558 · 2025: $971.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,102 · Education: $1,195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,102.13 |
| Education | $1,194.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $502.11 | 2022-2025 | Padcev, Xtandi |
| Astrazeneca Pharmaceuticals LP | $470.19 | 2022-2025 | Enhertu, Lynparza, Imfinzi |
| Novartis Pharmaceuticals Corporation | $425.80 | 2022-2025 | |
| Seagen INC. | $409.73 | 2022-2024 | Padcev, Adcetris |
| Incyte Corporation | $374.37 | 2022-2024 | Pemazyre, Monjuvi, Jakafi |
| Janssen Biotech, INC. | $323.99 | 2022-2025 | Darzalex, Tecvayli, Talvey |
| Pfizer INC. | $238.75 | 2024-2025 | |
| Abbvie INC. | $197.89 | 2024-2025 | |
| Eisai INC. | $195.41 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $194.08 | 2022-2025 | Keytruda, Welireg |
| Sanofi-Aventis U.S. LLC | $177.99 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $142.76 | 2023-2025 | Opdivo |
| Glaxosmithkline, LLC. | $119.42 | 2023-2025 | Jemperli, Zejula, Ojjaara |
| Puma Biotechnology, INC. | $118.72 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $116.72 | 2023-2024 | Libtayo |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Poonam Rai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.